|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net revenue | |||||
| Patent license | |||||
| Live Events | |||||
| Consumer audio products, components, and other | |||||
| Total net revenue | |||||
| Cost of net revenue | |||||
| Patent license | |||||
| Live Events | |||||
| Consumer audio products, components, and other | |||||
| Total cost of net revenue | |||||
| Gross profit | |||||
| Operating Expenses: | |||||
| Research and development | |||||
| Sales and marketing | |||||
| General and administrative | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Interest expense, net | |||||
| Change in fair value of convertible notes | |||||
| Change in fair value of convertible note to related party | |||||
| Change in fair value of warrant liability | |||||
| Other expense, net | |||||
| Loss before provision for income taxes | |||||
| Provision for income tax expense | |||||
| Net loss | |||||
| Deemed dividend on conversion of convertible preferred for common stock | |||||
| Deemed dividend on conversion of Series B preferred for common stock and repurchase of Series B preferred stock | |||||
| Net loss attributable to common stockholders | |||||
| Net loss per common share- basic (in dollars per share) | |||||
| Net loss per common share- diluted (in dollars per share) | |||||
| Weighted average number of common shares used in computing net loss per common share - Basic (in shares) | |||||
| Weighted average number of common shares used in computing net loss per common share - Diluted (in shares) | |||||
Loading...